Crestor Lawsuit Information



	Crestor Information


Home Browse Categories Harmful Drugs Vioxx Celebrex Bextra COX-2 Inhibitors Crestor Neurontin Zyprexa Ephedra Strattera Remicade Accutane Serzone Serevent Tamoxifen Baycol Fen Phen Rezulin Meridia PPA Propulsid Arava Permax Anti-Depressants OxyContin Tysabri Pemoline Defective Medical Devices Guidant Defibrillators Guidant Ancure Device Sulzer Hip Replacement Contraceptive Devices Breast Implants Toxic Substances Welding Rods Asbestos Mesothelioma Lead Poisoning Silica Medical Malpractice Cerebral Palsy Erb's Palsy Birth Injury Surgical Mistake Cancer Misdiagnosis Nursing Home Negligence Hospital Negligence Accidents Car Accidents Plane Accidents Boat Accidents Bus Accidents Motorcycle Accidents Brain Injury Spinal Cord Injury Dodge Truck and SUV Recall Other Injuries Insurance Bad Faith Slip and Fall Dog Bite Injury Inadequate Security Recall Forum Consumer Products Sexual Abuse Product Liability General Inquiries		Crestor has been associated with the following adverse side effects, according to the Public Citizen's latest petition: 7 patients with rhabdomyolysis 4 patients with acute kidney failure 5 additional patients with kidney damage 6 patients with bleeding or abnormal bleeding tests who were also using blood thinning drugs such as coumadin In addition, the Public Citizen reports that the FDA has received 65 reports of rhabdomyolysis and 29 cases of acute renal failure or renal insufficiency out of 4.5 million Crestor prescriptions, which is similar to the rate associated with Baycol. Crestor, known generically as Rosuvastatin, was approved by the Food and Drug Administration (FDA) on August 14, 2003 for the treatment of high-cholesterol. Manufactured by AstraZeneca, Crestor reduces cholesterol levels by blocking the liver from producing bad cholesterol (LDL). Crestor became the sixth cholesterol lowering "statin" drug on the U.S. market, following drugs like Lipitor, Pravachol and Zocor. Only three months after its approval, three patients in the United States who were taking approved doses of rosuvastatin developed Crestor side effects, including kidney failure or muscle damage. As in the case with Baycol, a cholesterol-lowering medicine withdrawn from the market by Bayer due to its serious side effects in August 2002, the muscle damage, known as rhabdomyolysis deteriorates the kidneys. The Public Citizen filed a petition to the FDA just months after Crestor's approval in an effort to prevent Crestor from being sold due to concerns over kidney toxicity. In studies before Crestor's approval, seven people were struck by cases of rhabdomyolysis. Since the original Public Citizen petition was filed with the FDA in early March, the organization said, eleven additional cases of muscle damage, ten of them in the United States, and three additional cases of kidney problems, have been reported. Symptoms of rhabdomyolysis and kidney damage include: muscle pain and weakness, general fatigue, fever, nausea and vomiting, and dark and discolored urine (reddish, rose, or cola colored urine). Rhabdomyolysis causes the blood serum levels of plasma creatine kinase (ck) levels to be very high. Acute kidney failure can occur and can cause death.